Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 211 results for "dr lal pathlabs"

Dr. Lal PathLabs informs about AGM

A dedicated place to get a comprehensive economic update, Interactive tools and to voice your opinions. News pertaining to Markets, Corporates, Industry, Economy, Mutual Fund and Business RBI Policy Indicators, Exchange Rates and General ... Finalaya.com, 3 weeks ago
Dr. Lal PathLabs' AGM on July 28, 2016 Money Control, 3 weeks ago
Dr. Lal PathLabs to hold board meeting Business Standard, 4 weeks ago
[x]  

19 images for dr lal pathlabs

Financial Express, 1 month ago
India Infoline, 2 months ago
Financial Express, 1 month ago
Livemint.com, 1 month ago
Moneycontrol.com, 1 month ago
DNA, 1 month ago
Moneycontrol.com, 2 months ago
Financial Express, 1 month ago
Livemint.com, 2 months ago
Business Standard India, 2 months ago
Financial Express

Dr Lal PathLabs shares rally on eyeing 18% growth in FY17

Dr Lal PathLabs shares advanced over 5 per cent intraday on Monday after the company said it is eyeing to attain around 18 per cent growth in its top-line in the ongoing financial
 Financial Express1 month ago Dr Lal PathLabs eyeing 18 pc growth in FY17  Times of India1 month ago Dr Lal PathLabs eyeing 18% growth in FY17  Money Control1 month ago Dr Lal PathLabs eyeing 18 per cent growth in FY17  Economic Times1 month ago
[x]  
VC Circle

Dr Lal PathLabs to play volume game, says CEO Manchanda

Gurgaon-based Dr Lal PathLabs Ltd is India's second-largest diagnostics chain. The company, backed by private equity firms TA Associates and WestBridge, made a spectacular debut on stock markets in December last year. It has a network of 171... ...
 VC Circle1 month ago Dr Lal PathLabs CEO on expansion, competing with PE-backed players and more  VC Circle1 month ago

Expect Dr Lal PathLabs to surpass industry growth in FY17: CEO

CEO Om Manchanda expects planned expansion of central lab network in Kolkata and Lucknow will help Dr Lal PathLabs to sustain margins in FY17. Diagnostics space which has low penetration in India makes it a good pitch for companies like Dr Lal PathLab, ...
 Money Control1 month ago Diagnostic industry is growing at 17% & we continue to see same momentum: Om Manchanda, CEO, Dr Lal PathLabs  Economic Times1 month ago May outperform industry's 17% FY17 growth rate forecast: Dr Lal  Money Control1 month ago Diagnostic sector is growing at 17% & we continue to see same momentum: Om Manchanda, CEO, Dr Lal PathLabs  Economic Times1 month ago

Dr Lal Pathlabs standalone net profit rises 28.09% in the March 2016 quarter

Sales rise 14.96% to Rs 191.29 crore Net profit of Dr Lal Pathlabs rose 28.09% to Rs 32.47 crore in the quarter ended March 2016 as against Rs 25.35 crore during the previous quarter ended March 2015. Sales rose 14.96% to Rs 191.29 crore in the quarter ended ...
 Business Standard2 months ago Dr Lal Pathlabs consolidated net profit rises 19.79% in the March 2016 quarter  Business Standard2 months ago
Money Control

Dr Lal PathLabs to acquire Delta Ria and Pathology

Diagnostics chain Dr Lal PathLabs has decided to acquire Delta Ria and Pathology, and purchase additional 10% stake each in two group companies Paliwal Diagnostics and Paliwal Medicare to raise its stake to 80%. Delta Ria and Pathology will be ...
 VC Circle1 month ago Dr. Lal PathLabs approves acquisition of Delta Ria and Pathology  Reuters UK2 months ago
[x]  

Fortis to chart new course of action for SRL Diagnostics

SRL Diagnostic will soon be vertically demerged from its parent company After the successful listing of Dr Lal Pathlabs in December 2015 and recently Thyrocare's success in the stock market has enthused the promoter company of SRL Diagnostics to ...
 Financial Express1 month ago
India Infoline

Dr. Lal Pathlabs Q4 net profit surges 20% to Rs.35 crore

*Password should have 8 to 12 Alphanumeric Characters with one Special Character. Confirm Password I want to create a User ID and have read the terms and conditions for the same Register Now Connect with We encourage visitors to register on IIFL. Registering ...
 India Infoline1 month ago DR LAL PATHLABS' : Q4 net profit surges 20% to Rs.35 crore  4 Traders1 month ago Buy Dr Lal Pathlabs, target Rs 1140: Citigroup  Economic Times1 month ago Dr Lal Pathlabs: Q4 numbers set to impress Dalal Street  India Infoline2 months ago
[x]  

Diagnostic chain Supratech hires Motilal Oswal to find buyers

Supratech CEO Sandip Shah says they have hired an investment banker, but are yet to make a final decision on stake dilution plans Mumbai: Several regional diagnostic chains are seeking investors, hoping to tap into the interest in the sector ...
 Livemint.com2 days ago

L&T Infotech Shares Turn Flat After Disappointing Debut

L&T Infotech shares made a disappointing debut in stock markets on Thursday, falling as much as 6.2 per cent to Rs 666 against their issue price of Rs 710. L&T Infotech, part of the diversified Larsen & Toubro group, joined the list of about a dozen ...
 NDTV Profit1 week ago L&T Infotech shares make weak debut, slump 6%  MSN News US1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less